 His pattern is predictable. This company is next.
Dear Friend,
Musk needed batteries. He built the Gigafactory.
Needed solar. Acquired SolarCity.
Needed data. Bought Twitter.
The pattern is clear: when a supplier becomes mission-critical, Musk doesn't negotiate. He acquires.
Right now, the most critical supplier in his $1.75 trillion empire is a small power infrastructure company — the one building the equipment Colossus literally can't run without.
For Musk, acquiring it would be pocket change.
For investors who own it before that happens, it could be life-changing.
Dylan Jovine has the name and ticker.
See the stock Musk's playbook says he needs >>
"The Buck Stops Here,"
Kelly Maguire
Behind the Markets
Further Reading from MarketBeat.com
3 Overlooked Nuclear Fuel Supply Chain WinnersReported by Nathan Reiff. Article Published: 4/26/2026. 
Key Points
- Global nuclear power capacity is on pace to more than double in the coming decades, and demand is rising quickly.
- Companies occupying unique spaces in the nuclear fuel supply chain—providing unique enriched products, special components for reactors, and so on—may have an advantageous position as the industry continues to grow.
- Centrus Energy, Uraniun Energy, and BWX Technologies could all be worth a closer look for this reason.
- Special Report: These AI stocks could go to zero. Here's why.
The International Atomic Energy Agency recently increased its projections for global nuclear power capacity for a fifth straight year, and it now expects capacity to more than double by 2050. Still, nuclear energy is unfamiliar enough to many investors that they may not fully understand the intricacies of the nuclear fuel supply chain, including mining, enrichment, fabrication, reactor operation, waste disposal, and more. With nuclear power seeing steadily rising demand from data center applications and other uses, companies operating as pick-and-shovel plays within the nuclear supply chain could be positioned to benefit in a significant way. Investors can therefore look beyond pure-play mining firms for an innovative approach to the nuclear energy space. Major Provider of a Critical Enriched Product Sees Big Boost From DEA Contract
Centrus Energy Corp. (NYSE: LEU) provides nuclear fuel enrichment services and is, in fact, the only American firm licensed to produce high-assay, low-enriched uranium (HALEU). This type of highly energy-dense uranium is vital for fueling many types of nuclear reactors, meaning Centrus effectively has a monopoly on a critical corner of the market. This advantageous position has led to significant wins for Centrus in recent quarters. Late in 2025, for example, the company won a $900 million HALEU enrichment award from the Department of Energy. Structured as a procurement contract, the award will help Centrus increase its HALEU production capacity. All of this has led to strong financial results for Centrus. In 2025, revenue climbed to nearly $449 million, while backlog reached $3.8 billion, extending to 2040. Although LEU shares have nearly tripled over the last year, they are down fairly sharply this year, having fallen by about 10% year-to-date. Part of this has to do with a few precarious elements of its business, including reliance on Russian supplies and rapidly rising capital expenditures. Still, half of the analysts rating LEU view the stock as a Buy, and the consensus price target suggests nearly 25% upside potential may be in store. Low-Cost In-Situ Production Gives Uranium Energy Corp. a Margin EdgeWhen it comes to uranium mining firms, Uranium Energy Corp. (NYSEAMERICAN: UEC) stands out as a key—but often overlooked—domestic producer of yellowcake, the uranium concentrate that represents an intermediate step in uranium processing. In its latest quarter, Uranium Energy produced nearly 45,800 pounds of the substance. What makes Uranium Energy important for investors to know is that its in-situ recovery process keeps costs quite low. During the same period, the cash cost to the firm was only about $40 per pound of yellowcake. It also sold some 200,000 pounds of yellowcake for more than $100 per pound, leading to $20 million in revenue and about half that much in gross profit. Uranium's low-cost production process has helped it build a solid cash position of more than $800 million as of the latest earnings report and has kept it debt-free in the process. With nearly 1.5 million pounds of yellowcake inventory on hand, the company is well-positioned to continue supplying these raw materials to nuclear energy firms across the production cycle for the foreseeable future. This may be why, despite also tripling over the last year, shares of UEC are projected to rise by about 16%. Rapid Medical Industry Growth Fuels BWX's ExpansionBWX Technologies Inc. (NYSE: BWXT) is a provider of nuclear components and services, with a particular focus on propulsion systems for naval nuclear reactors. The company thus has a niche focus on the defense industry, but it also produces small modular reactors and components for non-defense uses, including for the medical industry. BWX's multi-sector approach has paid off well—last quarter, the company closed 2025 with revenue up 18% year over year and earnings per share up 20%. Free cash flow and adjusted EBITDA also climbed thanks to strong commercial operations. In particular, the company's medical segment reached $100 million in annual revenue. This makes BWX an appealing nuclear energy play for investors keen to explore beyond the data center application. Acquisitions and new facilities are helping BWX expand rapidly, and the company has done so without jeopardizing its financial position. Indeed, it reduced interest costs and increased liquidity to $1.7 billion by the end of 2025. On top of all this, BWX also offers investors a modest dividend bonus. Analysts are strongly bullish on BWXT, as more than two-thirds of those rating the stock have called it a Buy or equivalent. . |
0 التعليقات:
إرسال تعليق